SKIN
SKIN 1-star rating from Upturn Advisory

Beauty Health Co (SKIN)

Beauty Health Co (SKIN) 1-star rating from Upturn Advisory
$0.97
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

02/26/2026: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

2 star rating from financial analysts

9 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $2.03

1 Year Target Price $2.03

Analysts Price Target For last 52 week
$2.03 Target price
52w Low $0.78
Current$0.97
52w High $2.69
Advertisement

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 113.27M USD
Price to earnings Ratio -
1Y Target Price 2.03
Price to earnings Ratio -
1Y Target Price 2.03
Volume (30-day avg) 9
Beta 1.15
52 Weeks Range 0.78 - 2.69
Updated Date 02/26/2026
52 Weeks Range 0.78 - 2.69
Updated Date 02/26/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.16

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.89%
Operating Margin (TTM) -8.83%

Management Effectiveness

Return on Assets (TTM) -2.92%
Return on Equity (TTM) -18.73%

Valuation

Trailing PE -
Forward PE 106.38
Enterprise Value 380334174
Price to Sales(TTM) 0.38
Enterprise Value 380334174
Price to Sales(TTM) 0.38
Enterprise Value to Revenue 1.23
Enterprise Value to EBITDA 18.37
Shares Outstanding 127503059
Shares Floating 82576081
Shares Outstanding 127503059
Shares Floating 82576081
Percent Insiders 11.67
Percent Institutions 90.48

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Beauty Health Co

Beauty Health Co(SKIN) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Beauty Health Co. (NASDAQ: BHSC) was formed through a SPAC merger with Rustic Canyon Acquisition Corp., with the transaction closing in August 2021. The company is a global, multi-brand company that operates in the beauty and wellness sector, with a focus on aesthetic treatments. Its core brand, Hydrafacial, is a well-established name in the skincare industry, known for its signature facial treatments.

Company business area logo Core Business Areas

  • Aesthetic Device Segment: This segment primarily focuses on the sale and servicing of Hydrafacial devices, which are professional-grade aesthetic machines used in dermatology clinics, medspas, and other professional settings to perform signature skin treatments. These devices utilize patented vortex-fusion technology for exfoliation, extraction, and hydration.
  • Consumables and Skincare Segment: This segment encompasses the sale of proprietary serums, boosters, and other skincare products designed to be used with Hydrafacial devices. This includes partnerships with various skincare brands to offer customized treatment protocols.
  • Services and Support: Beauty Health Co. also provides ongoing maintenance, training, and support services for its devices, ensuring optimal performance and customer satisfaction.

leadership logo Leadership and Structure

Beauty Health Co. is led by a management team with experience in the beauty, wellness, and technology sectors. The company operates globally, with a network of distributors and partners in numerous countries. The exact structure and names of key leadership personnel can be found in their SEC filings and investor relations materials.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Hydrafacial Device: The flagship product is the Hydrafacial device, which offers a multi-step treatment for skin rejuvenation. It is widely recognized and has a strong brand presence in professional aesthetic settings. Competitors include other professional facial treatment systems and devices offered by companies like Lumenis, Candela Medical, and various smaller players in the aesthetic device market. Specific market share data for individual devices is not readily available but Hydrafacial is a leading brand in its segment.
  • Hydrafacial Synergistic Formulations (Boosters): These are proprietary serums and boosters designed to enhance the Hydrafacial treatment experience and address specific skin concerns such as fine lines, hydration, and brightening. These are often co-branded with well-known skincare ingredients and brands. Competitors include a wide array of professional skincare brands and customized treatment protocols offered by other aesthetic providers.

Market Dynamics

industry overview logo Industry Overview

The global aesthetic and personal care industry is experiencing robust growth, driven by increasing consumer interest in appearance, aging populations, and advancements in technology. The demand for non-invasive and minimally invasive cosmetic procedures is particularly strong. The professional skincare segment, where Beauty Health Co. operates, is a significant part of this market.

Positioning

Beauty Health Co. is positioned as a leading provider of advanced, non-invasive aesthetic facial treatments with its Hydrafacial brand. Its key competitive advantages include a strong brand recognition, a patented technology, a wide global distribution network, and a recurring revenue model through consumables and service contracts. The company also benefits from its ability to partner with other skincare brands and professionals.

Total Addressable Market (TAM)

The total addressable market for aesthetic and personal care treatments is substantial and growing, estimated to be in the tens of billions of dollars globally. Beauty Health Co. is positioned within the professional aesthetic devices and treatments segment, which represents a significant portion of this TAM. Their focus on non-invasive facial treatments places them in a high-growth sub-segment.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition of Hydrafacial.
  • Patented and proprietary vortex-fusion technology.
  • Global distribution network and established relationships with aesthetic professionals.
  • Recurring revenue from consumables and service contracts.
  • Partnership opportunities with established skincare brands.

Weaknesses

  • Reliance on a core product (Hydrafacial device).
  • Potential for increased competition from new technologies and direct-to-consumer offerings.
  • Susceptibility to economic downturns impacting discretionary spending on aesthetic treatments.
  • Integration risks from past and future acquisitions.

Opportunities

  • Expansion into emerging markets.
  • Development of new device technologies and treatment protocols.
  • Increased penetration in underserved demographics.
  • Leveraging data and AI to personalize treatments.
  • Further strategic acquisitions to expand product portfolio and market reach.

Threats

  • Intensifying competition from both established players and new entrants.
  • Changes in consumer preferences and aesthetic trends.
  • Regulatory changes affecting medical devices and aesthetic treatments.
  • Supply chain disruptions and rising raw material costs.
  • Potential for negative publicity or adverse events related to treatments.

Competitors and Market Share

Key competitor logo Key Competitors

  • Lumenis (Multiple Stock Symbols)
  • Candela Medical (Private)
  • Cutera (CUTR)
  • Venus Concept (VERO)
  • InMode (INMD)

Competitive Landscape

Beauty Health Co. holds a strong position in the professional facial treatment device market due to its established Hydrafacial brand and technology. Its advantages lie in brand loyalty and a comprehensive service ecosystem. However, competitors are actively innovating with new technologies and pricing strategies. The competitive landscape is fragmented with various players focusing on different aspects of the aesthetic market, from laser treatments to energy-based devices.

Major Acquisitions

Healthx

  • Year: 2023
  • Acquisition Price (USD millions):
  • Strategic Rationale: The acquisition of Healthx was aimed at expanding Beauty Health Co.'s portfolio into medical aesthetics, particularly in the dermatology and plastic surgery segments, and to enhance its presence in key international markets.

HydraFacial Company

  • Year: 2021
  • Acquisition Price (USD millions):
  • Strategic Rationale: This was part of the SPAC transaction that formed Beauty Health Co., integrating the established Hydrafacial brand into a publicly traded entity to fuel further growth and investment.

Growth Trajectory and Initiatives

Historical Growth: Beauty Health Co. has experienced rapid growth in recent years, driven by organic expansion of the Hydrafacial brand and strategic acquisitions, notably the acquisition of Healthx. This has diversified its offerings and expanded its geographical reach.

Future Projections: Future growth is expected to be driven by continued international expansion, innovation in product development (new devices and formulations), and further synergistic acquisitions. Analyst estimates for future revenue and earnings growth should be consulted for specific projections.

Recent Initiatives: Key recent initiatives include the integration of acquired companies to realize synergies, expansion of direct-to-consumer engagement, and the launch of new product lines and treatment protocols to enhance customer value and drive device utilization.

Summary

Beauty Health Co. is a strong player in the growing aesthetic treatment market, leveraging the popular Hydrafacial brand. Its proprietary technology, global reach, and recurring revenue model are significant strengths. However, the company faces increasing competition and is reliant on continued innovation and successful integration of acquisitions to maintain its growth trajectory. Careful monitoring of market trends and competitive pressures is essential.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Beauty Health Co. SEC Filings (10-K, 10-Q)
  • Investor Relations Websites
  • Financial News Outlets
  • Industry Reports

Disclaimers:

This information is for informational purposes only and does not constitute financial advice. Market share data is estimated and may vary depending on the source and methodology. Financial performance data should be verified with the company's official filings. Stock symbols provided are for illustrative purposes and may change.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Beauty Health Co

Exchange NASDAQ
Headquaters Long Beach, CA, United States
IPO Launch date 2020-11-24
CEO & President Mr. Pedro Malha
Sector Consumer Defensive
Industry Household & Personal Products
Full time employees 769
Full time employees 769

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.